Incidence, risk factors, and outcomes of anti-tuberculosis drug-induced hepatotoxicity in people with and without HIV in Thailand and the Philippines
Asian Biomedicine · 01.06.2026 · 20 (3) · 170-181
DOI: 10.2478/abm-2026-0020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Biomedicine, online erschienen am 30.06.2026. Verfasst von Ryan Christopher Geturbos Atuel und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Global Health, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Anti-tuberculosis drug-induced hepatotoxicity (DIH) is a common complication among people living with HIV (PLWH), potentially leading to treatment interruptions.
Objective
To determine the incidence of DIH and identify risk factors in Thai and Filipino PLWH on tuberculosis (TB) treatment, compared with those with TB mono-infection.
Methods
We conducted a cohort study of Thai and Filipino adults with active TB using retrospective data from Thailand (2000–2024) and prospective data from the Philippines (2024). DIH was defined as AST or ALT ≥3 times the upper limit of normal. Logistic regression was used to assess DIH risk factors among PLWH; TB treatment outcomes were compared by DIH status.
Results
Among 222 participants (138 PLWH, 84 HIV-negative), median age was 38 years, 63% were male, and median body mass index (BMI) was 18.2 kg/m 2 . DIH occurred in 13.8% of PLWH and 9.5% of HIV-negative individuals ( P = 0.35), with median onset at 10 and 3 weeks, respectively. Among PLWH, hepatitis C co-infection (aOR 5.84, 95% CI 1.51–22.55, P = 0.01) and lower BMI (aOR 0.78/kg/m 2 , 95% CI 0.63–0.97, P = 0.03) were independently associated with DIH. Dolutegravir use showed a non-significantly lower DIH risk (OR 0.51, 95%CI, 0.18 – 1.42). TB treatment success was similar between those with and without DIH (92.6% vs 90.3%); mortality was slightly higher with DIH (3.7% vs 1.5%).
Conclusions
Hepatitis C co-infection and low BMI are key risk factors for DIH among PLWH receiving TB treatment. Despite these risks, DIH did not significantly impact treatment outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Global Health, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
- TB HIV Innovations and Clinical Research Corp., Cavite 4118, Philippines.
- HIV-NAT, Thai Red Cross AIDS and Infectious Diseases Research Centre, Bangkok 10330, Thailand.
- Division of Infectious Diseases, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand.
- Center of Excellence in Tuberculosis, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
- Research Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
Zitieren
APA
Atuel, R. C. G., Gutierrez, E. A., Hiranburana, N., Apornpong, T., Ubolyam, S., Gler, M. T. S., Avihingsanon, A., Gatechompol, S., & Kerr, S. J. (2026). Incidence, risk factors, and outcomes of anti-tuberculosis drug-induced hepatotoxicity in people with and without HIV in Thailand and the Philippines. Asian Biomedicine, 20(3), 170-181. https://doi.org/10.2478/abm-2026-0020
Vancouver
Atuel RCG, Gutierrez EA, Hiranburana N, Apornpong T, Ubolyam S, Gler MTS, et al. Incidence, risk factors, and outcomes of anti-tuberculosis drug-induced hepatotoxicity in people with and without HIV in Thailand and the Philippines. Asian Biomedicine. 2026;20(3):170-181. doi:10.2478/abm-2026-0020
BibTeX
@article{Atuel2026,
author = {Atuel, Ryan Christopher Geturbos and Gutierrez, Emmanuel A and Hiranburana, Napon and Apornpong, Tanakorn and Ubolyam, Sasiwimol and Gler, Ma Tarcela S and Avihingsanon, Anchalee and Gatechompol, Sivaporn and Kerr, Stephen J},
title = {Incidence, risk factors, and outcomes of anti-tuberculosis drug-induced hepatotoxicity in people with and without HIV in Thailand and the Philippines},
journal = {Asian Biomedicine},
year = {2026},
volume = {20},
number = {3},
pages = {170--181},
doi = {10.2478/abm-2026-0020}
}
EUVIMED